July 16th, 2023

Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS) announced positive topline results from the Phase 1 INTERCEPT-AD trial evaluating the company's ACU193, a clinical-stage antibody therapy targeting amyloid beta oligomers (AβOs) in early Alzheimer's di. Read more

July 16th, 2023

On Tuesday, July 18, several companies are anticipated to report their financial results, including: The PNC Financial Services Group, Inc. (NYSE: PNC), a financial services corporation, is set to issue its financial results for the second quarter. Read more

July 16th, 2023

On Tuesday, July 18, several companies are expected to report their financial results, including: Bank of America Corporation (NYSE: BAC), a financial giant, is set to reveal its second-quarter 2023 financial results before the market opens. . Read more

July 15th, 2023

Seagen Inc. (Nasdaq: SGEN) and Pfizer Inc. (NYSE: PFE) have encountered a regulatory hurdle in their planned merger. According to a regulatory filing with the SEC, both companies received a Second Request from the Federal Trade Commission (FTC) on Ju. Read more

July 14th, 2023

In a decisive move, U.S. Secretary of State Antony J. Blinken has announced the designation of former Panamanian President Juan Carlos Varela Rodriguez as generally ineligible for entry into the United States due to his involvement in significant cor. Read more

July 14th, 2023

Inogen, Inc. (Nasdaq: INGN) issued a preliminary, unaudited financial update for the second quarter of 2023, revealing lower-than-expected revenue figures. The company estimates that total revenue for the quarter will fall within the range of $83 . Read more

July 14th, 2023

JPMorgan Chase & Co. (NYSE: JPM), a leading global financial services firm, delivered strong financial results in the second quarter of 2023, surpassing market expectations. The company reported adjusted earnings per share (EPS) of $4.37, outperformi. Read more

July 14th, 2023

Shares of Nokia Oyj (NYSE: NOK) experienced a significant decline in pre-market trading following the company's downward revision on its financial guidance for the full year 2023. The new net sales outlook for the year is expected to be in the ran. Read more

July 13th, 2023

Silver Spring, MD / CRWE PRESS RELEASE / July 13, 2023 -  Today, the U.S. Food and Drug Administration approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy— the first daily oral contraceptive approved for us. Read more

July 13th, 2023

EHang Holdings Limited (Nasdaq: EH) has partnered with the Bao'an District Government of Shenzhen municipality to advance urban air mobility (UAM) using EH216-S AAVs. The collaboration aims to develop UAM use cases, establish a demonstration center i. Read more